Siemens Healthineers AG (OTCMKTS:SMMNY) Given Average Rating of “Strong Buy” by Analysts

Shares of Siemens Healthineers AG (OTCMKTS:SMMNY) have earned a consensus rating of “Strong Buy” from the six research firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, one has issued a buy recommendation and four have given a strong buy recommendation to the company.

SMMNY has been the topic of a number of research analyst reports. Hsbc Global Res raised Siemens Healthineers from a “hold” rating to a “strong-buy” rating in a report on Friday, April 25th. HSBC raised shares of Siemens Healthineers to a “buy” rating in a research note on Friday, April 25th. Berenberg Bank raised shares of Siemens Healthineers to a “strong-buy” rating in a report on Thursday, January 30th. Finally, DZ Bank upgraded Siemens Healthineers from a “hold” rating to a “strong-buy” rating in a research report on Friday, May 16th.

Siemens Healthineers Price Performance

Shares of SMMNY stock opened at $26.35 on Wednesday. The firm has a fifty day moving average price of $26.34 and a 200-day moving average price of $27.21. Siemens Healthineers has a 1 year low of $23.28 and a 1 year high of $30.19.

Siemens Healthineers Company Profile

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.